Abstract l Background: Fischer rats were less susceptible to experimental autoimmune uveoretinits (EAU) than Lewis rats, although both strains have the same MHC molecules. The purpose of this study was to compare the susceptibility of experimental allergic/immunemediated blepharoconjunctivitis (EAC) between these two strains. l Methods: Male Lewis and Fischer rats were immunized with either ovalbumin (OVA) or OVA peptide (OVA 323±339 ) in complete Freund's adjuvant (CFA). Three weeks later, they were challenged with OVA by eye drops. Twenty-four hours later, after clinical evaluation, they were killed and eyes, blood and lymph nodes were harvested for histology, antibody titer and proliferation assay, cytokine production or flow cytometric analysis, respectively. l Results: Fischer rats developed mild EAC compared with Lewis rats. Cellular proliferative responses, IFNg production of culture supernatant and serum IgG specific for OVA were basically the same between the two strains. The same OVA peptides were selected as immunodominant. Flow cytometric analysis demonstrated the same cellular profile of lymph node cells in the two strains. l Conclusion: EAC in Fischer rats was milder than that in Lewis rats, although no apparent differences in immunological parameters between these two strains were detected. These data suggest that factors unrelated to immunological parameters may depend on the susceptibility of EAC.
Introduction
One important factor of susceptibility for allergic or autoimmune diseases is genetic background [2, 8] . To develop allergic reaction, involvement of T cells for disease induction is crucial [9] , either directly or indirectly by helping antibody production of B cells. For T cell recognition, antigenic peptides must be presented on major histocompatibility complexes (MHC) for contact with T cell receptor (TcR) [16] . In addition, certain peptides tend to bind to particular types of MHC molecules which have high polymorphism [15] . Therefore, susceptibility for T cell-mediated diseases largely depends on MHC differences [3, 11] .
Lewis rats are known to be susceptible to various kinds of T cell-mediated autoimmune disease models [1, 17] , including experimental autoimmune uveoretinitis (EAU) induced by immunization of uveitogenic proteins such as interphotoreceptor retinoid-binding protein (IRBP) [13] or retinal soluble antigen (S-Ag) [14] . Fox et al. [6] reported that Fischer rats, having the same MHC as Lewis rats, developed EAU by immunization with IRBP protein, although the intensity of disease is milder than that of Lewis rats. Caspi et al. [4] reported that Fischer rats were resistant for the induction of EAU by active immunization of IRBP derived peptide R16 in emulsion of complete Freund's adjuvant. They also demonstrated that injection of Bordetella pertussis toxin as an additional adjuvant abrogated the resistance to development of EAU in Fischer rats. They attributed this difference of EAU susceptibility to the IFN-g production ability of lymphocytes stimulated with R16. Hirose et al. [10] reported that immunization of either S-Ag or peptide M, a component of bovine S-Ag, could elicit EAU in Fischer rats as well as in Lewis rats, although the intensity of EAU in Fischer rats was milder than in Lewis rats. Taken together, Fischer rats were resistant to the induction of EAU by immunization of retinal autoantigens, although there were variations in severity of EAU among antigens or antigenic peptides.
Our groups established a model for human blepharoconjunctivitis in Lewis rats and termed this model experimental allergic/immune-mediated blepharoconjunctivits (EAC) [7] . EAC can be induced by active immunization of the model allergen (ovalbumin, OVA) with adjuvants which could induce strong cellular immunity. In addition, EAC is transferable into synergeneic recipient rats by injection of OVA-primed lymph node cells as well as OVA peptide 323±339 (OVA 323±339 )-specific, CD4-positive cells (submitted for publication). These results indicate that EAC is a cellular immunity-mediated disease and MHC molecules must be involved in disease induction.
This information led us to compare susceptibility of EAC in these two strains of rats, which have same MHC haplotypes. The data showed that Lewis rats were more susceptible than Fischer rats to EAC as well as EAU. In the system of EAC, no differences in immunological parameters, including IFN-g production, were detected between the two strains.
Materials and methods

Rats
Six-to 8-week-old male Lewis rats were purchased from Seac Yoshitomi, Fukuoka, Japan, and Fischer rats were from Clea Japan, Tokyo, Japan. All rats were maintained in a pathogen-free animal facility at Kochi Medical School. All animal procedures conformed to institutional guidelines and to the ARVO Resolution on Use of Animal in Research.
Antigen and peptide OVA (grade V, Sigma Immunochemicals, St. Lous, Mo.) and OVA peptide 323±339 (OVA 323±339 : ISQAVHAAHAEINEAGR) [12] were used for either immunizing or challenging antigens. OVA 323± 339 was synthesized by solid-phase chemistry using t-butyloxycarbonyl derivatives of the amino acid and purified by HPLC to at least 95% purity (Sawady Technology, Tokyo, Japan). OVA constitutive peptides were synthesized following the multipin method based on the amino acid sequence of OVA (Peptide Institute, Osaka, Japan). The number of amino acids of these overlapping peptides was 15, and each peptide overlaps 5 amino acids.
Antibodies
Anti-CD4 and anti-CD8 (Pharmingen, San Diego, Calif.) are FITClabeled. Anti-CD3, anti-CD25 (Pharmingen), anti-I-A (OX-3) and anti-CD45RA (OX-33) (Serotec, Oxford, UK) are biotin-labeled.
Sensitization, challenge and evaluation of EAC Rats were injected subcutaneously with 100 g of either OVA or OVA 323±339 in complete Freund's adjuvant (CFA; Yatoron, Tokyo, Japan). In addition, some of them received intravenous injection of 110 10 Bordetella pertussis bacteria (PT; Wako Pure Chemicals, Osaka, Japan). Three weeks later, they were challenged with OVA by eye drops as previously reported. Twenty-four hours after challenge, rats were clinically evaluated and killed, and eyes, blood and lymph nodes were harvested for histology, antibody production and proliferation assay respectively. Details on clinical and histological evaluation of the conjunctiva have been described elsewhere [7] . In brief, the eyes including the lids were fixed in 10% buffered formalin and embedded in paraffin. Sections 10 m thick were stained with hematoxylin-eosin, and the infiltrated cells were counted in the palpebral conjunctiva with an eyepiece grid of 400 magnification.
Assessment for cellular immune responses of primed lymph node cells Lymph nodes were combined per group, and experiments were repeated for at least three times. Lymphocyte proliferation assays were set up in quadruplicate in 96-well flat-bottom plates. Lymph node cells (310 5 cells/well) were cultured in a final volume of 0.2 ml RPMI 1640 medium supplemented with 5% fetal calf serum (FCS; ICN Biomedical Japan, Tokyo, Japan), 2-mercaptoethanol (2-ME; 510 5 M), l-glutamine (2 mM), penicillin (100 U/ml) and streptomycin (100 g/ml). Cells were stimulated with either OVA, OVA 323±339 or OVA constitutive peptides at final concentrations of 0.1, 1, 10 and 100 g/ml. After incubation for 72 h at 37 C in a humidified atmosphere with 5% CO 2 , cultures were pulsed for 16 h with 0.5 Ci/well of 3 H-thymidine (Japan Atomic Energy Research Institute, Tokai, Japan). Cultures were then harvested and the radioactivity was measured by standard techniques. Data were expressed as stimulation indices.
Assessment of humoral immune responses
Serum was collected from each rat via cardiac puncture at the time of death. Serum antibody levels against OVA were measured by direct ELISA. OVA (500 ng/well) were absorbed to 96-well plates for 2 h at 37 C. The plates were washed with PBS-Tween and serially serum samples were added to the wells. Bound antibody was detected by peroxidase-conjugated anti-IgG (Nordic Immunological Laboratories, Tilburg, The Netherlands). The plates developed using 3,3©,5,5©-tetramethylbenzidine base (TMB-ELISA, Gibco BRL; Gaithersburg, MD) and the optical density (OD) for each well was read at 610 nm.
Cytokine ELISA using culture supernatant Lymph nodes from either OVA-or OVA 323±339 -primed rats were combined for culture. Cells were prepared as described above. 10010 6 cells were cultured in 25-cm 2 flasks (Nunc, Roskilde, Denmark), with OVA at 50 g/ml in a final volume of 10 ml RPMI1640 medium containing 510 5 M of 2-ME and 10% FCS for 3 days. Culture supernatants were harvested and assayed by commercial cytokine ELISA (BioSource International, Camarillo, Calif.) for IFN-g concentrations strictly following the recommended method.
Results
Lewis rats were more susceptible to EAC than Fischer rats All the Lewis rats immunized and challened with OVA exhibited clinical EAC, while half of tested Fischer rats developed clinical EAC. The average clinical grading SE of Lewis rats was 2.90.2 (n=16) and that of Fischer rats was 0.90.3 (n=13) (Fig. 1a) . Figure 1b represents the infiltrated cell number per field of conjunctiva with EAC from either Lewis or Fischer rats. In agreement with clinical grading, more infiltrated cells detected in Lewis rats than in Fischer rats (Lewis n=167.1, Fischer, n=57.5). There were fewer than five inflammatory cells in the conjunctiva of non-sensitized control rats.
No differences between Lewis and Fischer rats for either cellular and humoral immunity against OVA To test the involvement of immunity in different susceptibility to EAC between Lewis and Fischer rats, we tested proliferation assay, IFN-g production of OVA-primed lymph node cells and OVA-specific IgG antibody in serum. The important notion is that the average number of cells recovered from Lewis rats is always about twice that from Fischer rats. As shown in Fig. 2a , proliferative responses of OVA-primed lymph node cells from the two strains were similar to each other, as well as IFN-g production in the culture supernatant (Fig. 2b) . In addition, OVA-specific humoral immunity detected by ELISA demonstrated that there were no clear differences in OVA-specific IgG production between these two rat strains (Fig. 2c) .
Lymph node cells immunized with OVA from both Lewis and Fischer rats recognized same pattern of epitopes
To investigate the fine specificity of cellular immune responses to OVA, we synthesized OVA overlapping peptides and tested the proliferative responses of OVAprimed lymph node cells from both strains against these peptides. Although the magnitude of responses for each fragment were different between the two strains, the selected patterns of epitopes were basically similar (Fig. 3) .
Phenotypical populations of lymph node cells were similar in Lewis and Fischer rats
As shown in Table 1 , there were no remarkable differences in T/B (CD3/CD45R) ratio, CD4/CD8 ratio or I-A expression between lymph node cells from OVAprimed Fischer and Lewis rats. Lewis rats were more susceptible for EAC than Fischer rats induced by OVA 323±339 with no differences in immunological parameters
To investigate the possible induction of EAC by immunization of OVA 323±339 , we immunized both strains of rats with this peptide in CFA. No remarkable differences in immune responses, evaluated by cellular proliferative responses as well as IFN-g production, were detected between the two strains (Table 3 ). The intensity of EAC of Fischer rats was much weaker than that of Lewis rats (Table 3) , just as when OVA protein is used for model allergen.
Discussion
The data presented here demonstrated that Lewis rats are more susceptible to EAC than Fischer rats, although no clear differences in immunological parameters against OVA were detected between these two strains.
In parallel with previous notions concerning EAU [4, 6, 10] , Fischer rats were resistant for the induction of EAC (Fig. 1) . Compared with the data of Caspi et al. [4] , lymph node cells from Fischer, rats proliferated against OVA (Fig. 2a) as well as producing IFN-g (Fig.  2b) on stimulation with OVA. These cells selected the same pattern of peptides of OVA sequence as the antigenic peptides. Population and subpopulation of lymph node cells were quite similar in both strains (Table 1) . From these data, there was no apparent difference in cellular immunity of OVA-primed lymph node cells against OVA between Fischer and Lewis rats. In addition, there was also no difference in humoral immunity (Fig. 2c) against OVA between these two strains. Therefore, it could be considered that factors not related to immunological parameters tested here may be important in the induction of severe EAC.
Compared to Caspi's report, as shown in Fig. 2b , production of IFN-g was not suppressed in Fischer rats. Furthermore, PT augmented neither EAC nor cellular proliferative responses to OVA (Table 2 ). These differences may depend on the nature of disease. Because EAU is targeted on retinal autoantigens, the number of immunocompetent cells for these antigens must be smaller than that for foreign antigens such as OVA. Taking the data of Fig. 1 into consideration, IFN-g may not be crucial for the augmentation to EAC.
It should be noted that the body size, weight and recovered lymph node cell number of Fischer rats were consistently smaller than those of Lewis rats. As we demonstrated that as few as 610 4 OVA 323±339 -specific T cells induced EAC (data not shown), and EAC was parallel with the induced cellular proliferative responses against OVA [7] , smaller numbers of recovered lymph node cells may not be important for resistance to EAC development in Fischer rats. Considering the physical differences between these two strains, it is obviously important to investigate hormonal conditions. Wilder's group [5, 18, 19] demonstrated that defective hormonal regulation in Lewis rats led to streptococcal cell wall arthritis, while efficient regulation inhibited the development of this disease in Fischer rats. Therefore, it should be considered that hormones such as corticosteroid are involved in susceptibility to EAC.
Previous reports tested the genetic susceptibility to EAU in these two strains using uveitogenic peptides such as M peptide [10] of S-Ag or R16 [4] of IRBP. In theory, immunization of a certain peptide should induce a clonal population of immunocompetent cells and enable us to Fig. 3 Proliferative responses of draining lymph node cells either from Lewis or Fischer rats against synthetic overlapping OVA constitutive peptides at 100 g/ml. OVA-primed lymph node cells from both strains of rats were tested for their proliferative responses against 15-mer synthetic overlapping peptides of OVA. X-axis indicates fragment number used. Data are means of SI values of three rats of each group. The combined mean cpm values in the unstimulated control cultures of rats were 2829 in Lewis rats and 28918 in Fischer rats avoid other factors not related to the target peptide for the induction of disease and immune responses. In this regard, we immunized rats with OVA 323±339 [12] which has high affinity to RT1.B and is capable of inducing EAC in Lewis rats (submitted for publication). According to data obtained using OVA protein, this peptide induced more cellular infiltration in Lewis rats than in Fischer rats, although immunological parameters were basically the same between the two strains. These data further supported the importance of non-immunological factors for susceptibility to EAC.
In conclusion, Fischer rats were less susceptible to experimental immune-mediated disease models than Lewis rats, regardless of antigens. This low susceptibility may largely depend on non-immunological factors such as corticosteroid hormone. Further studies are needed to identify the key factors which cause low susceptibility to EAU and EAC in Fischer rats.
